1. Home
  2. MPLT vs AIN Comparison

MPLT vs AIN Comparison

Compare MPLT & AIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$7.78

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Albany International Corporation

AIN

Albany International Corporation

SELL

Current Price

$60.24

Market Cap

1.8B

ML Signal

SELL

Company Overview

Basic Information
Metric
MPLT
AIN
Founded
2018
1895
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Textiles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2025
1994

Fundamental Metrics

Financial Performance
Metric
MPLT
AIN
Price
$7.78
$60.24
Analyst Decision
Strong Buy
Hold
Analyst Count
15
3
Target Price
$26.54
★ $67.67
AVG Volume (30 Days)
★ 420.3K
205.9K
Earning Date
12-03-2026
11-04-2026
Dividend Yield
N/A
★ 1.84%
EPS Growth
★ 82.39
N/A
EPS
N/A
★ 1.14
Revenue
N/A
★ $1,054,132,000.00
Revenue This Year
N/A
$9.92
Revenue Next Year
N/A
$6.29
P/E Ratio
★ N/A
$53.52
Revenue Growth
N/A
★ 7.29
52 Week Low
$7.85
$41.15
52 Week High
$40.43
$77.00

Technical Indicators

Market Signals
Indicator
MPLT
AIN
Relative Strength Index (RSI) 22.05 48.91
Support Level N/A $58.46
Resistance Level $20.46 $63.90
Average True Range (ATR) 0.58 1.71
MACD -0.04 0.22
Stochastic Oscillator 11.14 54.49

Price Performance

Historical Comparison
MPLT
AIN

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

About AIN Albany International Corporation

Albany International Corp is a textiles and materials processing company specializing in engineered fabrics and composite components and assemblies for the paper, industrial manufacturing and aerospace industries. It operates through two segments: Machine Clothing, which produces custom-designed fabrics and high-speed process belts for paper, paperboard, tissue, towel and pulp, as well as engineered fabrics for other industrial applications, and contributes the majority of revenue; and Albany Engineered Composites, which provides engineered composite parts for the aerospace and defense industries. The company generates revenue from the United States, Switzerland, Brazil, China, Mexico, France and other areas.

Share on Social Networks: